Edition:
United Kingdom

Strides Pharma Science Ltd (SRID.NS)

SRID.NS on National Stock Exchange of India

413.00INR
8:17am BST
Change (% chg)

Rs0.15 (+0.04%)
Prev Close
Rs412.85
Open
Rs412.85
Day's High
Rs417.40
Day's Low
Rs406.95
Volume
582,134
Avg. Vol
1,289,951
52-wk High
Rs551.40
52-wk Low
Rs340.10

Latest Key Developments (Source: Significant Developments)

India's Strides Pharma Science March Qtr Consol Net Profit Falls
Friday, 10 May 2019 

May 10 (Reuters) - Strides Pharma Science Ltd ::MARCH QUARTER CONSOL NET PROFIT 475.1 MILLION RUPEES VERSUS PROFIT OF 5.69 BILLION RUPEES LAST YEAR.MARCH QUARTER CONSOL REVENUE FROM OPERATIONS 8.40 BILLION RUPEES VERSUS 6.70 BILLION RUPEES LAST YEAR.  Full Article

Vivimed Labs Says Report On Vivimed Life Sciences' Drug Recall Has No Effect Co's Business
Wednesday, 8 May 2019 

May 8 (Reuters) - Vivimed Labs Ltd ::CLARIFIES ON REPORT VIVIMED LIFE SCIENCES PVT LTD RECALLS HYPERTENSIVE DRUG FROM U.S. MARKET DUE TO IMPURITIES.AFTER SALE OF STAKE IN 50:50 JV WITH STRIDES, CO SOLD BALANCE 50% STAKE IN VIVIMED LIFE SCIENCES TO STRIDES PHARMA SCIENCE.NEWS REPORT HAS NO EFFECT ON BUSINESS OF VIVIMED LABS.  Full Article

Strides Pharma Science Says USFDA Classifies Puducherry Facility As OAI
Monday, 6 May 2019 

May 6 (Reuters) - Strides Pharma Science Ltd ::STRIDES PHARMA SCIENCE - GETS COMMUNICATION FROM USFDA CLASSIFYING PUDUCHERRY FACILITY AS OAI BASED ON INSPECTION CONDUCTED FROM JAN 28- 5TH FEBRUARY.STRIDES PHARMA SCIENCE LTD - CLASSIFICATION WILL NOT HAVE AN IMPACT ON CURRENT SUPPLIES AND REVENUES FROM FACILITY.STRIDES PHARMA SCIENCE - OF 34 ANDA’S PENDING APPROVAL, PUDUCHERRY HAS 10 ANDA’S WHERE CO EXPECTS DELAYS UNTIL FACILITY IS RECLASSIFIED.  Full Article

Strides Pharma Science Gets U.S FDA Approval For Its Greenfield Oral Dosage Facility In Singapore
Wednesday, 27 Mar 2019 

March 27 (Reuters) - Strides Pharma Science Ltd ::RECEIVES USFDA APPROVAL FOR ITS GREENFIELD ORAL DOSAGE FACILITY IN SINGAPORE.  Full Article

Strides Pharma Science Says Bajaj Finance Cuts Stake In Co By 3.49 Pct To 1.74 Pct
Thursday, 14 Mar 2019 

March 14 (Reuters) - Strides Pharma Science Ltd ::SAYS BAJAJ FINANCE CUTS STAKE IN CO BY 3.49 PERCENT TO 1.74 PERCENT.  Full Article

Strides Pharma Science Seeks Shareholders' Nod For Divestment Of Australian Business
Tuesday, 5 Mar 2019 

March 5 (Reuters) - Strides Pharma Science Ltd ::SEEKS SHAREHOLDERS' NOD FOR DIVESTMENT OF AUSTRALIAN BUSINESS.SEEKS SHAREHOLDERS' NOD FOR APPROVAL FOR DEALS WITH SOLARA ACTIVE PHARMA SCIENCES FOR UP TO 5 BILLION RUPEES IN EACH FY.  Full Article

Strides Pharma Science Gets U.S. FDA Approval For Ethosuximide Softgel Capsules
Wednesday, 20 Feb 2019 

Feb 20 (Reuters) - Strides Pharma Science Ltd ::SAYS RECEIVES USFDA APPROVAL FOR ETHOSUXIMIDE SOFTGEL CAPSULES.SAYS PRODUCT WILL BE MANUFACTURED AT FACILITY IN BANGALORE AND WILL BE MARKETED BY STRIDES PHARMA INC. IN U.S. .  Full Article

Strides Pharma Science Gets U.S. FDA Nod For Triamcinolone Acetonide Cream
Wednesday, 13 Feb 2019 

Feb 13 (Reuters) - Strides Pharma Science Ltd ::SAYS CO RECEIVES U.S. FDA APPROVAL FOR TRIAMCINOLONE ACETONIDE CREAM.  Full Article

Strides Pharma Science Says No Form 483 From U.S. FDA For Bangalore Facility
Wednesday, 6 Feb 2019 

Feb 6 (Reuters) - Strides Pharma Science Ltd ::SAYS EIR FROM U.S. FDA ON CONTINUED GMP STATUS FOR THE FACILITY IN BANGALORE.SAYS NO 483 OBSERVATIONS FROM U.S. FDA FOR THE FACILITY IN BANGALORE.  Full Article

Strides Pharma Science Commits $15 Mln To Stelis In $100 Mln Series B Fund Raising
Thursday, 22 Nov 2018 

Nov 22 (Reuters) - Strides Pharma Science Ltd ::STRIDES PHARMA SCIENCE- APPROVED PARTICIPATION IN SERIES B FUNDRAISER OF STELIS BIOPHARMA WITH COMMITMENT OF $15 MILLION IN A $100 MILLION FUND RAISE.  Full Article